Effectiveness of a dapsone compliance program in leprosy.
Long-term effectiveness of a dapsone compliance program was assessed in patients with leprosy. The monitoring program consists of urine dapsone/creatinine ratio determination at each visit with subsequent patient feedback and education. Eighty-eight patients receiving dapsone and seen in a leprosy clinic from 1985-1990 were included. The proportion of patients compliant with dapsone during a given year ranged from 70.0% (1987) to 94.4% (1989). Overall compliance for the 6-year period was 81.6%. This level of compliance was significantly different (P < 0.05) than the baseline compliance in the leprosy clinic of 46.7%. Compliance monitoring, combined with active patient involvement, was effective in sustaining high compliance over a 6-year period.